Avidity Biosciences
RNA
#1831
Rank
โ‚ฌ9.24 B
Marketcap
61,38ย โ‚ฌ
Share price
-0.06%
Change (1 day)
70.15%
Change (1 year)

Avidity Biosciences (RNA) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ1.83 Billion

According to Avidity Biosciences's latest financial reports the company's total assets are โ‚ฌ1.83 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Avidity Biosciences - Total assets on balance sheet (from 2019 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ1.50 B164.31%
2023-12-31โ‚ฌ0.56 B-4.52%
2022-12-31โ‚ฌ0.59 B57.73%
2021-12-31โ‚ฌ0.37 B39.08%
2020-12-31โ‚ฌ0.27 B213.81%
2019-12-31โ‚ฌ86.5 M2385.25%
2018-12-31โ‚ฌ3.48 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
PTC Therapeutics
PTCT
โ‚ฌ2.26 B 23.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ69.99 M-96.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ2.99 B 63.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ0.90 B-50.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚ฌ0.29 B-83.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ179.09 B 9,680.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ70.75 B 3,763.74%๐Ÿ‡ฌ๐Ÿ‡ง UK